交易概述2025年8月15日,广州银诺医药集团股份有限公司(“银诺医药”,2591.HK)成功在香港联合交易所主板挂牌上市。招银国际担任银诺医药在香港IPO的联席账簿管理人及联席牵头经办人。银诺医药此次全球发行36,556,400股H股,发行价格为每股H股18.68港元,总募集金额约6.8亿港元。本次发行共有5位基石投资者,总认购金额约1,000万美元,占基础发行规模约11.49%。公司是亚洲...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.